IPI
Intrepid Potash, Inc. NYSE Listed Apr 22, 2008$38.62
Mkt Cap $518.8M
52w Low $22.55
57.8% of range
52w High $50.34
50d MA $39.75
200d MA $32.01
P/E (TTM)
46.2x
EV/EBITDA
4.8x
P/B
1.1x
Debt/Equity
0.0x
ROE
2.3%
P/FCF
14.1x
RSI (14)
—
ATR (14)
—
Beta
1.40
50d MA
$39.75
200d MA
$32.01
Avg Volume
339.8K
Intrepid Potash, Inc., together with its subsidiaries, engages in the extraction and production of the potash in the United States and internationally. It operates through three segments: Potash, Trio, and Oilfield Solutions. The Potash segment offers muriate of potash or potassium chloride for use as a fertilizer input in the agricultural market; as a component in drilling and fracturing fluids for oil and gas wells, as well as an input to other industrial processes in the industrial market; and as a nutrient supplement in the animal feed market. The Trio segment provides Trio, a specialty fertilizer that delivers potassium, sulfate, and magnesium in a single particle. The Oilfield Solutions segment sells water for use in the oil and gas services industry; and offers potassium chloride real-time mixing services on location for hydraulic fracturing operations and trucking services. The company also offers salt for use in animal feeds, industrial applications, pool salts, and treatment of roads and walkways for ice melting or to manage road conditions; magnesium chloride for use in the deicing and dedusting of roads; brines for well development and completion activities in the oil and gas industry; and metal recovery salt, a combination of potash and salt to enhance the recovery of aluminum in the aluminum recycling processing facilities. Intrepid Potash, Inc. was founded in 2000 and is based in Denver, Colorado.
1001 17th Street · Denver, CO 80202 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | 0.48 | 0.62 | +29.2% | 37.67 | +5.0% | +2.5% | — | — | — | — | — |
| Mar 4, 2026 | AMC | 0.26 | 0.49 | +88.5% | 36.06 | +0.7% | +10.6% | +6.7% | -0.8% | -3.1% | +8.1% | — |
| Nov 5, 2025 | AMC | 0.13 | 0.11 | -15.4% | 26.18 | -7.4% | -8.6% | +5.3% | +4.2% | +1.6% | -0.6% | — |
| Aug 6, 2025 | AMC | 0.17 | 0.45 | +164.7% | 31.03 | +1.5% | -5.3% | -2.6% | +0.3% | +0.7% | +0.3% | — |
| May 5, 2025 | AMC | -0.12 | 0.39 | +425.0% | 32.57 | +8.4% | +17.3% | -0.9% | +0.2% | +0.4% | -6.4% | — |
| Mar 3, 2025 | AMC | -0.05 | -0.11 | -120.0% | 24.61 | -5.8% | -2.0% | +7.0% | +2.5% | +0.5% | -3.3% | — |
| Nov 4, 2024 | AMC | -0.13 | -0.14 | -7.7% | 26.72 | -0.1% | +7.7% | -6.7% | +3.8% | -0.7% | +0.2% | — |
| Aug 5, 2024 | AMC | -0.00 | -0.06 | -1298.4% | 22.08 | +1.6% | +5.3% | -7.2% | +0.9% | +0.1% | -1.2% | — |
| May 8, 2024 | AMC | -0.11 | -0.14 | -31.2% | 21.07 | +2.0% | +16.7% | +0.4% | +3.4% | +1.1% | -3.1% | — |
| Mar 6, 2024 | AMC | -0.21 | -0.41 | -95.2% | 21.40 | -1.2% | +5.8% | -10.8% | +0.2% | -1.3% | -3.7% | — |
| Nov 8, 2023 | AMC | -0.11 | -0.53 | -381.8% | 19.76 | +0.0% | -6.2% | -1.4% | +0.1% | +9.1% | +2.1% | — |
| Aug 2, 2023 | AMC | 0.44 | 0.33 | -25.0% | 26.78 | -2.2% | -6.7% | +8.5% | -1.5% | -0.3% | +4.0% | — |
| May 3, 2023 | AMC | 0.67 | 0.37 | -44.8% | 25.51 | -4.7% | -16.3% | -2.1% | -3.6% | -1.3% | -2.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5 | UBS | Maintains | Sell → Sell | — | $36.06 | $36.30 | +0.7% | +10.6% | +6.7% | -0.8% | -3.1% | +8.1% |
| Jan 12 | UBS | Maintains | Sell → Sell | — | $30.16 | $31.12 | +3.2% | +4.1% | +1.1% | +7.2% | +1.2% | -3.4% |
| Aug 7 | UBS | Maintains | Sell → Sell | — | $31.03 | $31.51 | +1.5% | -5.3% | -2.6% | +0.3% | +0.7% | +0.3% |
| Jul 23 | UBS | Maintains | Sell → Sell | — | $34.12 | $34.58 | +1.3% | +7.0% | +0.7% | -2.4% | -2.0% | +0.5% |
| Apr 16 | UBS | Maintains | Sell → Sell | — | $29.17 | $28.62 | -1.9% | +0.8% | -1.1% | -1.2% | +4.3% | -0.1% |
| Mar 4 | UBS | Maintains | Sell → Sell | — | $24.61 | $23.19 | -5.8% | -2.0% | +7.0% | +2.5% | +0.5% | -3.3% |
| Jan 28 | UBS | Maintains | Sell → Sell | — | $26.83 | $26.70 | -0.5% | -2.3% | +3.2% | +0.2% | -3.0% | +1.0% |
| Nov 5 | UBS | Maintains | Sell → Sell | — | $26.72 | $26.69 | -0.1% | +7.7% | -6.7% | +3.8% | -0.7% | +0.2% |
| May 10 | BMO Capital | Maintains | Market Perform → Market Perform | — | $24.59 | $24.67 | +0.3% | +0.4% | +3.4% | +1.1% | -3.1% | +0.2% |
| Nov 10 | BMO Capital | Maintains | Market Perform → Market Perform | — | $18.54 | $18.39 | -0.8% | -1.4% | +0.1% | +9.1% | +2.1% | -3.8% |
| May 5 | BMO Capital | Maintains | Market Perform → Market Perform | — | $21.36 | $21.88 | +2.4% | -2.1% | -3.6% | -1.3% | -2.0% | -0.8% |
| Jan 11 | UBS | Maintains | Sell → Sell | — | $31.05 | $30.41 | -2.1% | -1.7% | +5.5% | -0.4% | +0.5% | -2.0% |
| Nov 4 | BMO Capital | Maintains | Market Perform → Market Perform | — | $34.24 | $35.14 | +2.6% | +5.8% | -0.6% | +1.0% | -8.9% | +7.5% |
| Jul 13 | UBS | Maintains | Sell → Sell | — | $38.07 | $37.05 | -2.7% | +0.5% | -3.7% | +3.3% | +3.2% | +5.7% |
| Jan 4 | UBS | Maintains | Sell → Sell | — | $44.56 | $46.38 | +4.1% | +2.8% | -5.0% | -1.8% | -1.1% | -2.2% |
| Nov 25 | Dahlman Rose | Downgrade | Hold → Sell | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | Cowen & Co. | Downgrade | Market Perform → Underperform | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | Cowen & Co. | Upgrade | Underperform → Perform | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | UBS | Downgrade | Neutral → Sell | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | Goldman Sachs | Maintains | Neutral → Neutral | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | KeyBanc | Downgrade | Buy → Hold | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | PiperJaffray | Downgrade | Overweight → Neutral | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | Scotiabank | Downgrade | Outperform → Perform | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | Scotiabank | Upgrade | Sector Underperform → Perform | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | Stephens & Co. | Upgrade | Equal Weight → Overweight | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | Susquehanna | Downgrade | Neutral → Sell | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | Susquehanna | Maintains | Neutral → Neutral | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | Susquehanna | Upgrade | Negative → Neutral | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | UBS | Maintains | Sell → Sell | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | CLSA | Maintains | Outperform → Buy | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | Barclays | Downgrade | Equal Weight → Underweight | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | Wunderlich | Maintains | Buy → Buy | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | Vertical Research | Downgrade | Buy → Hold | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | BMO Capital | Downgrade | Market Perform → Underperform | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | BMO Capital | Maintains | Market Perform → Perform | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | BMO Capital | Upgrade | Underperform → Perform | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | BGC Financial | Upgrade | Hold → Buy | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | BGC Financial | Downgrade | Buy → Hold | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 25 | CLSA | Downgrade | Buy → Underperform | — | $14.19 | $14.06 | -0.9% | -4.8% | +3.1% | -7.1% | +4.9% | +0.8% |
| Nov 4 | BMO Capital | Maintains | Market Perform → Market Perform | — | $9.18 | $9.35 | +1.9% | -4.7% | +3.5% | -3.3% | +4.2% | +7.8% |
| Nov 4 | Roth Capital | Maintains | Buy → Buy | — | $9.18 | $9.35 | +1.9% | -4.7% | +3.5% | -3.3% | +4.2% | +7.8% |
| Jul 9 | UBS | Maintains | Sell → Sell | — | $8.48 | $8.41 | -0.9% | -8.6% | +1.0% | -1.7% | +4.1% | +11.0% |
| Oct 31 | BMO Capital | Maintains | Market Perform → Market Perform | — | $39.00 | $39.90 | +2.3% | +1.3% | +3.0% | -1.7% | +0.2% | +3.2% |
| Aug 6 | BMO Capital | Maintains | Market Perform → Market Perform | — | $36.20 | $35.70 | -1.4% | -3.9% | -3.2% | +5.0% | +0.3% | -1.1% |
| May 9 | Stephens & Co. | Upgrade | Equal Weight → Overweight | — | $40.50 | $41.20 | +1.7% | -2.2% | +3.3% | +0.7% | +5.1% | +7.4% |
| Mar 5 | Cowen & Co. | Upgrade | Underperform → Market Perform | — | $35.60 | $38.20 | +7.3% | +11.8% | +1.5% | +0.7% | -4.2% | +2.8% |
| Dec 5 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $36.00 | $36.10 | +0.3% | +1.9% | -3.0% | +2.8% | +1.1% | +1.1% |
| Oct 31 | BMO Capital | Maintains | Market Perform → Market Perform | — | $37.10 | $37.80 | +1.9% | +8.4% | -2.7% | +3.3% | -1.0% | +0.3% |
No insider trades available.
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
BMO and IPI entered a material agreement with HydroSource Logistics, potentially expanding distribution capabilities or operational efficiency, which could improve margins and revenue growth trajectories for both companies.
Apr 2
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
IPI's CFO departure creates near-term uncertainty and potential operational strain, as the interim replacement lacks dedicated CFO focus, signaling possible financial instability or governance concerns investors should monitor closely.
Mar 16
8-K
Intrepid Potash, Inc -- 8-K Filing
Intrepid Potash delivered strong 2025 results with $298.3 million in full-year sales and $11.2 million net income, driven by record Trio product volumes and improving pricing dynamics.
Mar 4
Data updated apr 25, 2026 4:05pm
· Source: massive.com